|Title:||Abandoning clinical trial safeguards won’t boost local industry|
|Citation:||Komesaroff P, Thomson C, Kerridge I, (2013) Abandoning clinical trial safeguards won’t boost local industry, The Conversation|
|Abstract:||Testing new drugs in clinical trials is a billion-dollar industry in Australia, with most of the money coming from international pharmaceutical companies. But as investment grows in India, China, and other emerging competitors, some people argue we need to make Australia more attractive to such investment. One of their solutions is to water down the ethics approval process.|
|Type of Work:||Article|
|Appears in Collections:||Research Papers and Publications. Sydney Health Ethics|
|TheConv-abandoning-clinical-trial-safeguards-2013.pdf||230.69 kB||Adobe PDF|
Items in Sydney eScholarship Repository are protected by copyright, with all rights reserved, unless otherwise indicated.